MTORC1 signaling controls multiple steps in ribosome biogenesis

Seminars in Cell and Developmental Biology

Volumn 36, Issue , 2014, Pages 113-120

  Iadevaia, Valentina ^a   Liu, Rui ^a   Proud, Christopher G ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

5' TOP; Mammalian target of rapamycin; MTOR; MTOR complex 1; Rapamycin; Ribosomal protein; RNA polymerase; RRNA

Indexed keywords

DNA DIRECTED RNA POLYMERASE; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MESSENGER RNA; RIBOSOME DNA; RNA 5S; RNA POLYMERASE II; DNA DIRECTED RNA POLYMERASE III; MECHANISTIC TARGET OF RAPAMYCIN COMPLEX 1; MULTIPROTEIN COMPLEX; RIBOSOME PROTEIN; RIBOSOME RNA; TARGET OF RAPAMYCIN KINASE;

BIOGENESIS; CYTOPLASM; DNA TRANSCRIPTION; ENZYME REGULATION; FEEDBACK SYSTEM; HUMAN; NONHUMAN; REVIEW; RIBOSOME; RNA SYNTHESIS; RNA TRANSCRIPTION; RNA TRANSLATION; SIGNAL TRANSDUCTION; BIOSYNTHESIS; GENETICS; METABOLISM; PROTEIN SYNTHESIS;

MAMMALIA;

HUMANS; MULTIPROTEIN COMPLEXES; PROTEIN BIOSYNTHESIS; RIBOSOMAL PROTEINS; RIBOSOMES; RNA POLYMERASE I; RNA POLYMERASE III; RNA, RIBOSOMAL; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

EID: 84912533536     PISSN: 10849521     EISSN: 10963634     Source Type: Journal    
DOI: 10.1016/j.semcdb.2014.08.004     Document Type: Review

References (94)

1. Pianese G. Beitraege zur Histologie und Aetiologie der Carconoms. Beitr Pathol Anat Allgem Pathol 1896, 142:1-193.
2. Manning B.D., Cantley L.C. Rheb fills a GAP between TSC and TOR. Trends Biochem Sci 2003, 28:573-576.
3. Carriere A., Romeo Y., costa-Jaquez H.A., Moreau J., Bonneil E., Thibault P., et al. ERK1/2 phosphorylate Raptor to promote Ras-dependent activation of mTOR complex 1 (mTORC1). J Biol Chem 2011, 286:567-577.
4. Roux P.P., Ballif B.A., Anjum R., Gygi S.P., Blenis J. Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase. Proc Natl Acad Sci USA 2004, 101:13489-13494.
5. Fonseca B.D., Alain T., Finestone L.K., Huang B.P., Rolfe M., Jiang T., et al. Pharmacological and genetic evaluation of proposed roles of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase (MEK), extracellular signal-regulated kinase (ERK), and p90RSK in the control of mTORC1 protein signaling by phorbol esters. J Biol Chem 2011, 286:27111-27122.
6. Jewell J.L., Guan K.L. Nutrient signaling to mTOR and cell growth. Trends Biochem Sci 2013, 38:233-242.
7. Sancak Y., Bar-Peled L., Zoncu R., Markhard A.L., Nada S., Sabatini D.M. Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids. Cell 2010, 141:290-303.
8. Inoki K., Zhu T., Guan K.L. TSC2 mediates cellular energy response to control cell growth and survival. Cell 2003, 115:577-590.
9. Inoki K., Ouyang H., Zhu T., Lindvall C., Wang Y., Zhang X., et al. TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth. Cell 2006, 126:955-968.
10. Fenton T.R., Gout I.T. Functions and regulation of the 70kDa ribosomal S6 kinases. Int J Biochem Cell Biol 2011, 43:47-59.
11. RSK1 and p70 S6 kinase. EMBO J 2001, 20:4370-4379.
12. Gingras A-C., Raught B., Sonenberg N. eIF4 translation factors: effectors of mRNA recruitment to ribosomes and regulators of translation. Annu Rev Biochem 1999, 68:913-963.
13. Schalm S.S., Fingar D.C., Sabatini D.M., Blenis J. TOS motif-mediated raptor binding regulates 4E-BP1 multisite phosphorylation and function. Curr Biol 2003, 13:797-806.
14. Schalm S.S., Blenis J. Identification of a conserved motif required for mTOR signaling. Curr Biol 2002, 12:632-639.
15. Karbstein K. Quality control mechanisms during ribosome maturation. Trends Cell Biol 2013, 23:242-250.
16. Zinzalla V., Stracka D., Oppliger W., Hall M.N. Activation of mTORC2 by association with the ribosome. Cell 2011, 144:757-768.
17. Oh W.J., Wu C.C., Kim S.J., Facchinetti V., Julien L.A., Finlan M., et al. mTORC2 can associate with ribosomes to promote cotranslational phosphorylation and stability of nascent Akt polypeptide. EMBO J 2010, 29:3939-3951.
18. Bratkovic T., Rogelj B. The many faces of small nucleolar RNAs. Biochim Biophys Acta 2014, 1839:438-443.
19. Robledo S., Idol R.A., Crimmins D.L., Ladenson J.H., Mason P.J., Bessler M. The role of human ribosomal proteins in the maturation of rRNA and ribosome production. RNA 2008, 14:1918-1929.
20. Rouquette J., Choesmel V., Gleizes P.E. Nuclear export and cytoplasmic processing of precursors to the 40S ribosomal subunits in mammalian cells. EMBO J 2005, 24:2862-2872.
21. Powers T., Walter P. Regulation of ribosome biogenesis by the rapamycin-sensitive TOR-signaling pathway in Saccharomyces cerevisiae. Mol Biol Cell 1999, 10:987-1000.
22. Iadevaia V., Zhang Z., Jan E., Proud C.G. mTOR signaling regulates the processing of pre-rRNA in human cells. Nucleic Acids Res 2012, 40:2527-2539.
23. Chauvin C., Koka V., Nouschi A., Mieulet V., Hoareau-Aveilla C., Dreazen A., et al. Ribosomal protein S6 kinase activity controls the ribosome biogenesis transcriptional program. Oncogene 2013, 33:474-483.
24. Ruvinsky I., Sharon N., Lerer T., Cohen H., Stolovich-Rain M., Nir T., et al. Ribosomal protein S6 phosphorylation is a determinant of cell size and glucose homeostasis. Genes Dev 2005, 19:2199-2211.
25. Rohrmoser M., Holzel M., Grimm T., Malamoussi A., Harasim T., Orban M., et al. Interdependence of Pes1, Bop1, and WDR12 controls nucleolar localization and assembly of the PeBoW complex required for maturation of the 60S ribosomal subunit. Mol Cell Biol 2007, 27:3682-3694.
26. Holzel M., Rohrmoser M., Schlee M., Grimm T., Harasim T., Malamoussi A., et al. Mammalian WDR12 is a novel member of the Pes1-Bop1 complex and is required for ribosome biogenesis and cell proliferation. J Cell Biol 2005, 170:367-378.
27. Lapik Y.R., Fernandes C.J., Lau L.F., Pestov D.G. Physical and functional interaction between Pes1 and Bop1 in mammalian ribosome biogenesis. Mol Cell 2004, 15:17-29.
28. Strezoska Z., Pestov D.G., Lau L.F. Functional inactivation of the mouse nucleolar protein Bop1 inhibits multiple steps in pre-rRNA processing and blocks cell cycle progression. J Biol Chem 2002, 277:29617-29625.
29. Strezoska Z., Pestov D.G., Lau L.F. Bop1 is a mouse WD40 repeat nucleolar protein involved in 28S and 5. 8S RRNA processing and 60S ribosome biogenesis. Mol Cell Biol 2000, 20:5516-5528.
30. Mayer C., Grummt I. Ribosome biogenesis and cell growth: mTOR coordinates transcription by all three classes of nuclear RNA polymerases. Oncogene 2006, 25:6384-6391.
31. Jorgensen P., Tyers M. How cells coordinate growth and division. Curr Biol 2004, 14:R1014-R1027.
32. Hannan K.M., Sanij E., Rothblum L.I., Hannan R.D., Pearson R.B. Dysregulation of RNA polymerase I transcription during disease. Biochim Biophys Acta 2013, 1829:342-360.
33. Grummt I., Smith V.A., Grummt F. Amino acid starvation affects the initiation frequency of nucleolar RNA polymerase. Cell 1976, 7:439-445.
34. Mahajan P.B. Modulation of transcription of rRNA genes by rapamycin. Int J Immunopharmacol 1994, 16:711-721.
35. Li H., Tsang C.K., Watkins M., Bertram P.G., Zheng X.F. Nutrient regulates Tor1 nuclear localization and association with rDNA promoter. Nature 2006, 442:1058-1061.
36. Tsang C.K., Liu H., Zheng X.F. mTOR binds to the promoters of RNA polymerase I- and III-transcribed genes. Cell Cycle 2010, 9:953-957.
37. Goodfellow S.J., Zomerdijk J.C. Basic mechanisms in RNA polymerase I transcription of the ribosomal RNA genes. Subcell Biochem 2013, 61:211-236.
38. Smith S.D., O'Mahony D.J., Kinsella B.T., Rothblum L.I. Transcription from the rat 45S ribosomal DNA promoter does not require the factor UBF. Gene Expr 1993, 3:229-236.
39. Panov K.I., Friedrich J.K., Russell J., Zomerdijk J.C. UBF activates RNA polymerase I transcription by stimulating promoter escape. EMBO J 2006, 25:3310-3322.
40. Beckmann H., Chen J.L., O'Brien T., Tjian R. Coactivator and promoter-selective properties of RNA polymerase I TAFs. Science 1995, 270:1506-1509.
41. Hempel W.M., Cavanaugh A.H., Hannan R.D., Taylor L., Rothblum L.I. The species-specific RNA polymerase I transcription factor SL-1 binds to upstream binding factor. Mol Cell Biol 1996, 16:557-563.
42. Sanij E., Hannan R.D. The role of UBF in regulating the structure and dynamics of transcriptionally active rDNA chromatin. Epigenetics 2009, 4:374-382.
43. Hannan K.M., Brandenburger Y., Jenkins A., Sharkey K., Cavanaugh A., Rothblum L., et al. mTOR-dependent regulation of ribosomal gene transcription requires S6K1 and is mediated by phosphorylation of the carboxy-terminal activation domain of the nucleolar transcription factor UBF. Mol Cell Biol 2003, 23:8862-8877.
44. Tuan J.C., Zhai W., Comai L. Recruitment of TATA-binding protein-TAFI complex SL1 to the human ribosomal DNA promoter is mediated by the carboxy-terminal activation domain of upstream binding factor (UBF) and is regulated by UBF phosphorylation. Mol Cell Biol 1999, 19:2872-2879.
45. Voit R., Schnapp A., Kuhn A., Rosenbauer H., Hirschmann P., Stunnenberg H.G., et al. The nucleolar transcription factor mUBF is phosphorylated by casein kinase II in the C-terminal hyperacidic tail which is essential for transactivation. EMBO J 1992, 11:2211-2218.
46. Berger A.B., Decourty L., Badis G., Nehrbass U., Jacquier A., Gadal O. Hmo1 is required for TOR-dependent regulation of ribosomal protein gene transcription. Mol Cell Biol 2007, 27:8015-8026.
47. Xiao L., Kamau E., Donze D., Grove A. Expression of yeast high mobility group protein HMO1 is regulated by TOR signaling. Gene 2011, 489:55-62.
48. James M.J., Zomerdijk J.C. Phosphatidylinositol 3-kinase and mTOR signaling pathways regulate RNA polymerase I transcription in response to IGF-1 and nutrients. J Biol Chem 2004, 279:8911-8918.
49. Tower J., Sollner-Webb B. Transcription of mouse rDNA is regulated by an activated subform of RNA polymerase I. Cell 1987, 50:873-883.
50. Zhao J., Yuan X., Frodin M., Grummt I. ERK-dependent phosphorylation of the transcription initiation factor TIF-IA is required for RNA polymerase I transcription and cell growth. Mol Cell 2003, 11:405-413.
51. Mayer C., Zhao J., Yuan X., Grummt I. mTOR-dependent activation of the transcription factor TIF-IA links rRNA synthesis to nutrient availability. Genes Dev 2004, 18:423-434.
52. Claypool J.A., French S.L., Johzuka K., Eliason K., Vu L., Dodd J.A., et al. Tor pathway regulates Rrn3p-dependent recruitment of yeast RNA polymerase I to the promoter but does not participate in alteration of the number of active genes. Mol Biol Cell 2004, 15:946-956.
53. Grewal S.S., Evans J.R., Edgar B.A. Drosophila TIF-IA is required for ribosome synthesis and cell growth and is regulated by the TOR pathway. J Cell Biol 2007, 179:1105-1113.
54. Shor B., Wu J., Shakey Q., Toral-Barza L., Shi C., Follettie M., et al. Requirement of the mTOR kinase for the regulation of Maf1 phosphorylation and control of RNA polymerase III-dependent transcription in cancer cells. J Biol Chem 2010, 285:15380-15392.
55. Kantidakis T., Ramsbottom B.A., Birch J.L., Dowding S.N., White R.J. mTOR associates with TFIIIC, is found at tRNA and 5S rRNA genes, and targets their repressor Maf1. Proc Natl Acad Sci USA 2010, 107:11823-11828.
56. Moir R.D., Willis I.M. Regulation of pol III transcription by nutrient and stress signaling pathways. Biochim Biophys Acta 2013, 1829:361-375.
57. Michels A.A., Robitaille A.M., Buczynski-Ruchonnet D., Hodroj W., Reina J.H., Hall M.N., et al. mTORC1 directly phosphorylates and regulates human MAF1. Mol Cell Biol 2010, 30:3749-3757.
58. Lee J., Moir R.D., Willis I.M. Regulation of RNA polymerase III transcription involves SCH9-dependent and SCH9-independent branches of the target of rapamycin (TOR) pathway. J Biol Chem 2009, 284:12604-12608.
59. Huber A., Bodenmiller B., Uotila A., Stahl M., Wanka S., Gerrits B., et al. Characterization of the rapamycin-sensitive phosphoproteome reveals that Sch9 is a central coordinator of protein synthesis. Genes Dev 2009, 23:1929-1943.
60. Wei Y., Tsang C.K., Zheng X.F. Mechanisms of regulation of RNA polymerase III-dependent transcription by TORC1. EMBO J 2009, 28:2220-2230.
61. Caldarola S., Amaldi F., Proud C.G., Loreni F. Translational regulation of terminal oligopyrimidine mRNAs induced by serum and amino acids involves distinct signaling events. J Biol Chem 2004, 279:13522-13531.
62. Damgaard C.K., Lykke-Andersen J. Translational coregulation of 5'TOP mRNAs by TIA-1 and TIAR. Genes Dev 2011, 25:2057-2068.
63. Thoreen C.C., Chantranupong L., Keys H.R., Wang T., Gray N.S., Sabatini D.M. A unifying model for mTORC1-mediated regulation of mRNA translation. Nature 2012, 485:109-113.
64. Geyer P.K., Meyuhas O., Perry R.P., Johnson L.F. Regulation of ribosomal protein mRNA content and translation in growth-stimulated mouse fibroblasts. Mol Cell Biol 1982, 2:685-693.
65. Jefferies H.B.J., Reinhard G., Kozma S.C., Thomas G. Rapamycin selectively represses translation of the 'polypyrimidine tract' mRNA family. Proc Natl Acad Sci USA 1994, 91:4441-4445.
66. Hsieh A.C., Liu Y., Edlind M.P., Ingolia N.T., Janes M.R., Sher A., et al. The translational landscape of mTOR signalling steers cancer initiation and metastasis. Nature 2012, 485:55-61.
67. Crosio C., Boyl P.P., Loreni F., Pierandrei-Amaldi P., Amaldi F. La protein has a positive effect on the translation of TOP mRNAs in vivo. Nucleic Acids Res 2000, 28:2927-2934.
68. Cardinali B., Carissimi C., Gravina P., Pierandrei-Amaldi P. La protein is associated with terminal oligopyrimidine mRNAs in actively translating polysomes. J Biol Chem 2003, 278:35145-35151.
69. Pellizzoni L., Lotti F., Maras B., Pierandrei-Amaldi P. Cellular nucleic acid binding protein binds a conserved region of the 5' UTR of Xenopus laevis ribosomal protein mRNAs. J Mol Biol 1997, 267:264-275.
70. Tcherkezian J., Cargnello M., Romeo Y., Huttlin E.L., Lavoie G., Gygi S.P., et al. Proteomic analysis of cap-dependent translation identifies LARP1 as a key regulator of 5'TOP mRNA translation. Genes Dev 2014, 28:357-371.
71. S6k. EMBO J 1997, 16:3693-3704.
72. Pende M., Um S.H., Mieulet V., Sticker M., Goss V.L., Mestan J., et al. S6K1(-/-)/S6K2(-/-) mice exhibit perinatal lethality and rapamycin-sensitive 5'-terminal oligopyrimidine mRNA translation and reveal a mitogen-activated protein kinase-dependent S6 kinase pathway. Mol Cell Biol 2004, 24:3112-3124.
73. Orom U.A., Nielsen F.C., Lund A.H. MicroRNA-10a binds the 5'UTR of ribosomal protein mRNAs and enhances their translation. Mol Cell 2008, 30:460-471.
74. Shama S., Avni D., Frederickson R.M., Sonenberg N., Meyuhas O. Overexpression of initiation factor eIF-4E does not relieve the translational repression of ribosomal protein mRNAs in quiescent cells. Gene Expr 1995, 4:241-252.
75. Huo Y., Iadevaia V., Yao Z., Kelly I., Cosulich S., Guichard S., et al. Stable isotope-labelling analysis of the impact of inhibition of the mammalian target of rapamycin on protein synthesis. Biochem J 2012, 444:141-151.
76. Miloslavski R., Cohen E., Avraham A., Iluz Y., Hayouka Z., Kasir J., et al. Oxygen sufficiency controls TOP mRNA translation via the TSC-Rheb-mTOR pathway in a 4E-BP-independent manner. J Mol Cell Biol 2014, 6:255-266.
77. Mamane Y., Petroulakis E., Martineau Y., Sato T.A., Larsson O., Rajasekhar V.K., et al. Epigenetic activation of a subset of mRNAs by eIF4E explains its effects on cell proliferation. PLoS ONE 2007, 2:e242.
78. Loreni F., Thomas G., Amaldi F. Transcription inhibitors stimulate translation of 5' TOP mRNAs through activation of S6 kinase and the mTOR/FRAP signalling pathway. Eur J Biochem 2000, 267:6594-6601.
79. Liu R., Iadevaia V., Averous J., Taylor P.M., Zhang Z., Proud C.G. Impairing the production of ribosomal RNA activates mammalian target of rapamycin complex 1 signalling and downstream translation factors. Nucleic Acids Res 2014, 42:5083-5096.
80. Lohrum M.A., Ludwig R.L., Kubbutat M.H., Hanlon M., Vousden K.H. Regulation of HDM2 activity by the ribosomal protein L11. Cancer Cell 2003, 3:577-587.
81. Zhang Y., Wolf G.W., Bhat K., Jin A., Allio T., Burkhart W.A., et al. Ribosomal protein L11 negatively regulates oncoprotein MDM2 and mediates a p53-dependent ribosomal-stress checkpoint pathway. Mol Cell Biol 2003, 23:8902-8912.
82. Dai M.S., Lu H. Inhibition of MDM2-mediated p53 ubiquitination and degradation by ribosomal protein L5. J Biol Chem 2004, 279:44475-44482.
83. Donati G., Peddigari S., Mercer C.A., Thomas G. 5S ribosomal RNA is an essential component of a nascent ribosomal precursor complex that regulates the Hdm2-p53 checkpoint. Cell Rep 2013, 4:87-98.
84. Teng T., Thomas G., Mercer C.A. Growth control and ribosomopathies. Curr Opin Genet Dev 2013, 23:63-71.
85. Budanov A.V., Karin M. p53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling. Cell 2008, 134:451-460.
86. Feng Z., Hu W., de S.E., Teresky A.K., Jin S., Lowe S., et al. The regulation of AMPK beta1, TSC2, and PTEN expression by p53: stress, cell and tissue specificity, and the role of these gene products in modulating the IGF-1-AKT-mTOR pathways. Cancer Res 2007, 67:3043-3053.
87. Matthew E.M., Hart L.S., Astrinidis A., Navaraj A., Dolloff N.G., Dicker D.T., et al. The p53 target Plk2 interacts with TSC proteins impacting mTOR signaling, tumor growth and chemosensitivity under hypoxic conditions. Cell Cycle 2009, 8:4168-4175.
88. Havel J.J., Li Z., Cheng D., Peng J., Fu H. Nuclear PRAS40 couples the Akt/mTORC1 signaling axis to the RPL11-HDM2-p53 nucleolar stress response pathway. Oncogene 2014, 10.1038/onc. 2014.91.
89. Lam Y.W., Lamond A.I., Mann M., Andersen J.S. Analysis of nucleolar protein dynamics reveals the nuclear degradation of ribosomal proteins. Curr Biol 2007, 17:749-760.
90. Ben-Sahra I., Howell J.J., Asara J.M., Manning B.D. Stimulation of de novo pyrimidine synthesis by growth signaling through mTOR and S6K1. Science 2013, 339:1323-1328.
91. Robitaille A.M., Christen S., Shimobayashi M., Cornu M., Fava L.L., Moes S., et al. Quantitative phosphoproteomics reveal mTORC1 activates de novo pyrimidine synthesis. Science 2013, 339:1320-1323.
92. Laplante M., Sabatini D.M. An emerging role of mTOR in lipid biosynthesis. Curr Biol 2009, 19:R1046-R1052.
93. Bywater M.J., Poortinga G., Sanij E., Hein N., Peck A., Cullinane C., et al. Inhibition of RNA polymerase I as a therapeutic strategy to promote cancer-specific activation of p53. Cancer Cell 2012, 22:51-65.
94. Drygin D., Rice W.G., Grummt I. The RNA polymerase I transcription machinery: an emerging target for the treatment of cancer. Annu Rev Pharmacol Toxicol 2010, 50:131-156.